Efficacy and Safety of 4 Weeks of Treatment With Orally Inhaled BI1744/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease (COPD)
This study has been completed.
Study NCT00720499
Information provided by Boehringer Ingelheim Pharmaceuticals
First Received on July 21, 2008.
Last Updated on March 5, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
